logo
Verified
High Ratings
70+ Specializations
200+ Therapies
Research Phase I/II/III

About Specializations

Samodzielny Publiczny Szpital Kliniczny Nr 4 W Lublinie in Lublin, Poland specializes in artificial kidney clinical trials.

Medical Center localisation

Ul. Dr. Kazimierza Jaczewskiego 8
20-090 Lublin, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1 1 1 1
    Investigated drugs:
    Poland
  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Belgium Bulgaria Czechia Denmark France Germany +7
  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +4
  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Bulgaria Czechia Germany Lithuania Poland Romania +1
  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated drugs:
    Austria Bulgaria Croatia Czechia Germany Greece +9
  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated drugs:
    Ireland Poland Portugal Spain
  • Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Italy +2
  • Study on BI 764532 for Patients with Relapsed or Refractory Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

    Recruiting

    2 1 1
    Belgium Bulgaria France Germany Italy Poland +2
  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    3 1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland Germany Italy The Netherlands Poland
  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Belgium Bulgaria Czechia Denmark France Germany +7